Skip to Main Content

Paper Details

Germline Mutations in <i>CIDEB</i> and Protection against Liver Disease.
N Engl J Med
37
2022
Liver Disease, Rare coding variants, alanine, allele, aminotransferase, cirrhosis, hepatic lipid droplets, hepatoma, human, human hepatoma cell lines, liver aminotransferase, liver cirrhosis, liver disease, loss-of-function variants, nonalcoholic fatty liver disease, oleate, patients, persons, rare coding variants, rare protein-coding genetic variants, rare protein-coding variants, small interfering RNA, variants
Author NameAffiliation
Niek VerweijRegeneron Pharmaceuticals (M.G., NY Indiana University School of Medicine, Lund University, Skane University Hospital - both in Malmo, Perelman School of Medicine, University of Pennsylvania
George HindyRegeneron Pharmaceuticals (M.G., NY Indiana University School of Medicine, Lund University, Skane University Hospital - both in Malmo, Perelman School of Medicine, University of Pennsylvania
Olle MelanderRegeneron Pharmaceuticals (M.G., NY Indiana University School of Medicine, Lund University, Skane University Hospital - both in Malmo, Perelman School of Medicine, University of Pennsylvania
David J CareyRegeneron Pharmaceuticals (M.G., NY Indiana University School of Medicine, Lund University, Skane University Hospital - both in Malmo, Perelman School of Medicine, University of Pennsylvania
David J CareyRegeneron Pharmaceuticals (M.G., NY Indiana University School of Medicine, Lund University, Skane University Hospital - both in Malmo, Perelman School of Medicine, University of Pennsylvania
Christopher D StillRegeneron Pharmaceuticals (M.G., NY Indiana University School of Medicine, Lund University, Skane University Hospital - both in Malmo, Perelman School of Medicine, University of Pennsylvania
Tooraj MirshahiRegeneron Pharmaceuticals (M.G., NY Indiana University School of Medicine, Lund University, Skane University Hospital - both in Malmo, Perelman School of Medicine, University of Pennsylvania
Daniel J RaderRegeneron Pharmaceuticals (M.G., NY Indiana University School of Medicine, Lund University, Skane University Hospital - both in Malmo, Perelman School of Medicine, University of Pennsylvania
John D OvertonRegeneron Pharmaceuticals (M.G., NY Indiana University School of Medicine, Lund University, Skane University Hospital - both in Malmo, Perelman School of Medicine, University of Pennsylvania
John D OvertonRegeneron Pharmaceuticals (M.G., NY Indiana University School of Medicine, Lund University, Skane University Hospital - both in Malmo, Perelman School of Medicine, University of Pennsylvania
Jeffrey G ReidRegeneron Pharmaceuticals (M.G., NY Indiana University School of Medicine, Lund University, Skane University Hospital - both in Malmo, Perelman School of Medicine, University of Pennsylvania
Jeffrey G ReidRegeneron Pharmaceuticals (M.G., NY Indiana University School of Medicine, Lund University, Skane University Hospital - both in Malmo, Perelman School of Medicine, University of Pennsylvania
Andrew J MurphyRegeneron Pharmaceuticals (M.G., NY Indiana University School of Medicine, Lund University, Skane University Hospital - both in Malmo, Perelman School of Medicine, University of Pennsylvania
Gon??alo R AbecasisRegeneron Pharmaceuticals (M.G., NY Indiana University School of Medicine, Lund University, Skane University Hospital - both in Malmo, Perelman School of Medicine, University of Pennsylvania
Gon??alo R AbecasisRegeneron Pharmaceuticals (M.G., NY Indiana University School of Medicine, Lund University, Skane University Hospital - both in Malmo, Perelman School of Medicine, University of Pennsylvania
Viktoria GusarovaRegeneron Pharmaceuticals (M.G., NY Indiana University School of Medicine, Lund University, Skane University Hospital - both in Malmo, Perelman School of Medicine, University of Pennsylvania
George D YancopoulosRegeneron Pharmaceuticals (M.G., NY Indiana University School of Medicine, Lund University, Skane University Hospital - both in Malmo, Perelman School of Medicine, University of Pennsylvania
Hyun Min KangRegeneron Pharmaceuticals (M.G., NY Indiana University School of Medicine, Lund University, Skane University Hospital - both in Malmo, Perelman School of Medicine, University of Pennsylvania
Alan R ShuldinerRegeneron Pharmaceuticals (M.G., NY Indiana University School of Medicine, Lund University, Skane University Hospital - both in Malmo, Perelman School of Medicine, University of Pennsylvania
Alan R ShuldinerRegeneron Pharmaceuticals (M.G., NY Indiana University School of Medicine, Lund University, Skane University Hospital - both in Malmo, Perelman School of Medicine, University of Pennsylvania
Giusy Della GattaRegeneron Pharmaceuticals (M.G., NY Indiana University School of Medicine, Lund University, Skane University Hospital - both in Malmo, Perelman School of Medicine, University of Pennsylvania
Adam E LockeRegeneron Pharmaceuticals (M.G., NY Indiana University School of Medicine, Lund University, Skane University Hospital - both in Malmo, Perelman School of Medicine, University of Pennsylvania
Aris BarasRegeneron Pharmaceuticals (M.G., NY Indiana University School of Medicine, Lund University, Skane University Hospital - both in Malmo, Perelman School of Medicine, University of Pennsylvania
Luca A LottaRegeneron Pharmaceuticals (M.G., NY Indiana University School of Medicine, Lund University, Skane University Hospital - both in Malmo, Perelman School of Medicine, University of Pennsylvania
  • 1 - 24

Datasets

Release 1.2